NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/16/2023
Back to search
Official data from USPTO
STIMVIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
STIMVIA
ST13
US500000090814495Class
9, 10, 42, 44
Filing
90814495
Registration
7051655
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
07/08/2023
Trademark type
Word
Nice classes
9, 10, 42, 44
Filing date
07/07/2021
Registration date
05/16/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/16/2023
Last transaction
07/08/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
16
Owner location
Ostrava - Hulvaky, CZ
Examiner
MEIER, SHARON A
Law office
M30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Tesla Medical, s.r.o.
Representatives
Cathleen E. Stadecker DOWNS RACHLIN MARTIN PLLC
Technical classification
Nice Classes
Class 9Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Electrodes and devices for neurostimulation for scientific and research purposes; downloadable computer software for use in the design and use of medical instruments and devices used in neuromodulationelectrostimulation or electroceuticals treatment and therapy
Class 10
Medical electrodes for use in neuromodulationelectrostimulation or electroceuticals therapy and treatment of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility; medical instruments and devices for use in neuromodulation electrostimulation or electroceuticals treatment and therapy of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility
Class 42
Design and development of medical instruments and devices for use in neuromodulationelectrostimulation or electroceuticals therapy and treatment of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility; technology research in the field of medical instruments and devices for use in neuromodulationelectrostimulation or electroceuticals therapy and treatment of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility; medical and scientific research in the fields of urologyneurologygynecologyoncologyneurodegenerative diseasesoveractive bladderchronic diseases using neuromodulationelectrostimulation or electroceuticals treatment and therapy; providing medical and scientific research information in the fields of urologyneurologygynecologyoncologyneurodegenerative diseases and chronic diseases using electrostimulation or electroceuticals treatment or neuromodulation therapy and treatment; development of technology in the field of medical instruments and devices for neuromodulation therapy and treatment of low urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraine and infertility; design and development of computer software; software as a service (SAAS) services featuring software for use in the design and use of medical instruments and devices used in neuromodulation electrostimulation or electroceuticals treatment therapy and treatment; providing temporary use of on-line non-downloadable software for use in the design and use of medical instruments and devices used in electrostimulationelectroceuticals or neuromodulation treatment and therapy
Class 44
Medical services in the fields of urologyneurologygynecologyoncologyneurodegenerative diseasesoveractive bladderchronic diseases using electrostimulationelectroceuticals or neuromodulation treatment and therapy; providing medical information in the fields of urologyneurologygynecologyoncologyneurodegenerative diseasesoveractive bladderchronic diseases using electrostimulationelectroceuticals or neuromodulation treatment and therapy; medical treatment and therapy of urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraineinfertilityoveractive bladder and chronic diseases using electrostimulationelectroceuticals or neuromodulation treatment and therapy; rental of medical instruments and devices for use in electrostimulationelectroceuticals or neuromodulation treatment and therapy for urinary tract disfunctionParkinson's diseasesAlzheimer's diseasesbowel disfunctionepilepsymigraineinfertilityoveractive bladder or chronic diseases
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/28/2023
PUBO
PUBLISHED FOR OPPOSITION
02/28/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/08/2023
OTHE
CASE RETURNED TO EXAMINATION
01/20/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/28/2022
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
12/22/2022
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
12/22/2022
APET
ASSIGNED TO PETITION STAFF
12/20/2022
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
11/29/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/28/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/03/2022
PUBO
PUBLISHED FOR OPPOSITION
05/03/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/13/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/26/2022
DOCK
ASSIGNED TO EXAMINER
03/26/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2021
NWAP
NEW APPLICATION ENTERED
07/10/2021
Continuous trademark protection
Get notified about every new filing that threatens STIMVIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.